Reimbursement Experts Say Trial Endpoints Must Fit Add-On Payment Criteria
This article was originally published in The Gray Sheet
Executive Summary
Device firms intending to seek a new technology add-on payment for their technology should craft their pivotal clinical trial endpoints to meet CMS' substantial clinical improvement criteria, according to W.L. Gore associate Antoinette Sheen